PKMYT1-IN-1 (Compound 1) is an inhibitor for membrane-associated tyrosine and threonine kinase (PKMYT1), with an IC50 of 8.8 nM. PKMYT1-IN-1 inhibits proliferation of tumor cell HCC1569 with IC50 of 42 nM[1].

PKMYT1-IN-2 is a potent PKMYT1 inhibitor with an IC50 of 5.7 nM. PKMYT1-IN-2 inhibits the growth of HCC1569 cells with an IC50 of 22 nM (WO2024061343A1; compound 2)[1].

PKN1 Human Pre-designed siRNA Set A contains three designed siRNAs for PKN1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PKN2 Human Pre-designed siRNA Set A contains three designed siRNAs for PKN2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PKN3 Human Pre-designed siRNA Set A contains three designed siRNAs for PKN3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PKNOX1 Human Pre-designed siRNA Set A contains three designed siRNAs for PKNOX1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PKNOX2 Human Pre-designed siRNA Set A contains three designed siRNAs for PKNOX2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PKP1 Human Pre-designed siRNA Set A contains three designed siRNAs for PKP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PKP2 Human Pre-designed siRNA Set A contains three designed siRNAs for PKP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PKP3 Human Pre-designed siRNA Set A contains three designed siRNAs for PKP3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PKP4 Human Pre-designed siRNA Set A contains three designed siRNAs for PKP4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PLA1A Human Pre-designed siRNA Set A contains three designed siRNAs for PLA1A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PLA2G10 Human Pre-designed siRNA Set A contains three designed siRNAs for PLA2G10 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PLA2G12A Human Pre-designed siRNA Set A contains three designed siRNAs for PLA2G12A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PLA2G12B Human Pre-designed siRNA Set A contains three designed siRNAs for PLA2G12B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PLA2G15 Human Pre-designed siRNA Set A contains three designed siRNAs for PLA2G15 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PLA2G1B Human Pre-designed siRNA Set A contains three designed siRNAs for PLA2G1B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PLA2G2A Human Pre-designed siRNA Set A contains three designed siRNAs for PLA2G2A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PLA2G2D Human Pre-designed siRNA Set A contains three designed siRNAs for PLA2G2D gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PLA2G2E Human Pre-designed siRNA Set A contains three designed siRNAs for PLA2G2E gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PLA2G2F Human Pre-designed siRNA Set A contains three designed siRNAs for PLA2G2F gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PLA2G3 Human Pre-designed siRNA Set A contains three designed siRNAs for PLA2G3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PLA2G4A Human Pre-designed siRNA Set A contains three designed siRNAs for PLA2G4A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PLA2G4B Human Pre-designed siRNA Set A contains three designed siRNAs for PLA2G4B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PLA2G4C Human Pre-designed siRNA Set A contains three designed siRNAs for PLA2G4C gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PLA2G4D Human Pre-designed siRNA Set A contains three designed siRNAs for PLA2G4D gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PLA2G4E Human Pre-designed siRNA Set A contains three designed siRNAs for PLA2G4E gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PLA2G4F Human Pre-designed siRNA Set A contains three designed siRNAs for PLA2G4F gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PLA2G5 Human Pre-designed siRNA Set A contains three designed siRNAs for PLA2G5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PLA2G6 Human Pre-designed siRNA Set A contains three designed siRNAs for PLA2G6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PLA2G7 Human Pre-designed siRNA Set A contains three designed siRNAs for PLA2G7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PLA2R1 Human Pre-designed siRNA Set A contains three designed siRNAs for PLA2R1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PLAA Human Pre-designed siRNA Set A contains three designed siRNAs for PLAA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PLAAT1 Human Pre-designed siRNA Set A contains three designed siRNAs for PLAAT1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PLAAT3 Human Pre-designed siRNA Set A contains three designed siRNAs for PLAAT3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PLAAT4 Human Pre-designed siRNA Set A contains three designed siRNAs for PLAAT4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PLAC1 Human Pre-designed siRNA Set A contains three designed siRNAs for PLAC1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PLAC8 Human Pre-designed siRNA Set A contains three designed siRNAs for PLAC8 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PLAC9 Human Pre-designed siRNA Set A contains three designed siRNAs for PLAC9 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Pladienolide A can be isolated from Streptomyces platensis[1].

PLAG1 Human Pre-designed siRNA Set A contains three designed siRNAs for PLAG1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PLAGL1 Human Pre-designed siRNA Set A contains three designed siRNAs for PLAGL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PLAGL2 Human Pre-designed siRNA Set A contains three designed siRNAs for PLAGL2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.